Association of time in blood glucose range with outcomes following cardiac surgery

Amr S Omar, Ahmed Salama, Mahmoud Allam, Yasser Elgohary, Shaban Mohammed, Alejandro Kohn Tuli, Rajvir Singh, Amr S Omar, Ahmed Salama, Mahmoud Allam, Yasser Elgohary, Shaban Mohammed, Alejandro Kohn Tuli, Rajvir Singh

Abstract

Background: The importance of optimal postoperative glycemic control in cardiac patients remains unclear. Various glycemic targets have been prescribed to reduce wound infection and overall mortality rates.

Aim of the work: To assess glucose control, as determined by time in range (TIR), in patients with glycemic targets of 6.0 to 8.1 mmol/L, and to determine factors related to poor control.

Methods: This prospective descriptive study evaluated 227 consecutive patients, 100 with and 127 without diabetes, after cardiac surgery. Patients received insulin to target glucose concentrations of 6.0 to 8.1 mmol/L. Data analyzed included patient age, gender, race, Euro score, cardiopulmonary bypass time (CPB), aortic cross clamp time (ACC), length of ventilation, stay in the intensive care unit (ICU) and stay in the hospital. Patients were divided into two groups, those who maintained > 80% and < 80% TIR. Outcome variables were compared in diabetics and non-diabetics.

Results: Patients with >80% and <80% TIR were matched in age, sex, gender, and Euro score. Failure to maintain target glycemia was significantly more frequent in diabetics (p = 0.001), in patients with glycated hemoglobin (HbA1c) > 8% (p = 0.0001), and in patients taking dopamine (p = 0.04) and adrenaline (p = 0.05). Times of CPB and ACC, length of stay in the ICU and ventilation were significantly higher in patients with TIR <80% than >80%. Rates of hypoglycemia, acute kidney injury, and in-hospital mortality were similar in the two groups, although the incidence of wound infection was higher in patients with TIR <80%. Both diabetics and non-diabetics with low TIR had poorer outcomes, as shown by length of stay and POAF. No significant differences were found between the two ethnic groups (Arabs and Asians).

Conclusion: Patients with >80% TIR, whether or not diabetics, had better outcomes than those with <80% TIR, as determined by wound infection, lengths of ventilation and ICU stay. Additionally, they were not subject to frequent hypoglycemic events. Preoperatively high HbA1C is likely a good predictor of poor glycemic control.

Keywords: Glucose control; Outcome; Wound infection.

References

    1. Carr JM, Sellke FW, Fey M, Doyle MJ, Krempin JA, de la Torre R, Liddicoat JR. Implementing tight glucose control after coronary artery bypass surgery. Ann Thorac Surg. 2005;80(3):902–9. doi: 10.1016/j.athoracsur.2005.03.105.
    1. Ouattara A, Lecomte P, Le Manach Y, Landi M, Jacqueminet S, Platonov I, Bonnet N, Riou B, Coriat P. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology. 2005;103(4):687–94. doi: 10.1097/00000542-200510000-00006.
    1. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgical site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;22:607–12. doi: 10.1086/501830.
    1. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109:1497–502. doi: 10.1161/01.CIR.0000121747.71054.79.
    1. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Starr A. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007–21. doi: 10.1067/mtc.2003.181.
    1. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–67. doi: 10.1056/NEJMoa011300.
    1. Giakoumidakis K, Eltheni R, Patelarou E, Theologou S, Patris V, Michopanou N, Mikropoulos T, Brokalaki H. Effects of intensive glycemic control on outcomes of cardiac surgery. Heart Lung. 2013;42(2):146–51. doi: 10.1016/j.hrtlng.2012.12.007.
    1. Chaney MA, Nikolov MP, Blakeman BP, Bakhos M. Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia. Anesth Analg. 1999;89:1091–5. doi: 10.1213/00000539-199911000-00004.
    1. Lehot JJ, Piriz H, Villard J, Cohen R, Guidollet J. Glucose homeostasis. Comparison between hypothermic and normothermic cardiopulmonary bypass. Chest. 1992;102:106–11. doi: 10.1378/chest.102.1.106.
    1. Wasmuth HE, Kunz D, Graf J, Stanzel S, Purucker EA, Koch A, Lammert F. Hyperglycemia at admission to the intensive care unit is associated with elevated serum concentrations of interleukin-6 and reduced ex vivo secretion of tumor necrosis factor-alpha. Crit Care Med. 2004;32:1109–14. doi: 10.1097/01.CCM.0000124873.05080.78.
    1. Macheda M, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer [Review] J Cell Physiol. 2005;202:654–62. doi: 10.1002/jcp.20166.
    1. Ehtisham S, Crabtree N, Clark P, Shaw N, Barrett T. Ethnic differences in insulin resistance and body composition in United Kingdom adolescents. J Clin Endocrinol Metab. 2005;90(7):3963–9. doi: 10.1210/jc.2004-2001.
    1. Krinsley JS, Meyfroidt G, Van den Berghe G, Egi M, Bellomo R. The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients. Curr Opin Clin Nutr Metab Care. 2012;15(2):151–60. doi: 10.1097/MCO.0b013e32834f0009.
    1. Krinsley JS, Egi M, Kiss A, Devendra AN, Schuetz P, Maurer PM, Bellomo R. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care. 2013;17(2):R37. doi: 10.1186/cc12547.
    1. Moghissi E. Hospital management of diabetes: beyond the sliding scale. Cleve Clin J Med. 2004;71(10):801–8. doi: 10.3949/ccjm.71.10.801.
    1. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471. doi: 10.4065/78.12.1471.
    1. Falciglia M, Freyberg RW, Almenoff PL, D’Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37:3001. doi: 10.1097/CCM.0b013e3181b083f7.
    1. The NICE-SUGAR study investigators Intensive versus conventional glucose control in critically ill patients. NEJM. 2009;360:1283–97. doi: 10.1056/NEJMoa0810625.
    1. Lazar HL, McDonnell M, Chipkin SR, Furnary AP, Engelman RM, Sadhu AR, Bridges CR, Haan CK, Svedjeholm R, Taegtmeyer H, Shemin RJ. Society of thoracic surgeons blood glucose guideline task force. The society of thoracic surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87(2):663–9. doi: 10.1016/j.athoracsur.2008.11.011.
    1. Hargraves JD. Glycemic control in cardiac surgery: implementing an evidence-based insulin infusion protocol. Am J Crit Care. 2014;23(3):250–8. doi: 10.4037/ajcc2014236.
    1. Pezzella AT, Holmes SD, Pritchard G, Speir AM, Ad N. Impact of perioperative glycemic control strategy on patient survival after coronary bypass surgery. Annal Thorac Surg. 2014;98(4):1281–5. doi: 10.1016/j.athoracsur.2014.05.067.
    1. Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes. 2012;3(6):110. doi: 10.4239/wjd.v3.i6.110.
    1. Gauthier L, Ferguson J, Dubé AI, Nguyen PVQ, Beauchesne MF, Boutin JM. Assessment of quality of glycemic control in intensive care patients treated with an insulin infusion at a teaching hospital. Can J Diabetes. 2014;38(2):139–43. doi: 10.1016/j.jcjd.2014.01.012.
    1. Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. In Mayo Clinic Proc. 2005;80(12):1558–67. doi: 10.4065/80.12.1558.
    1. Whitcomb BA, Pradhan EK, Pittas AG, Roghmann MC, Perencevich EN. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med. 2005;33:2272–7. doi: 10.1097/01.CCM.0000189741.44071.25.
    1. Halkos ME, Lattouf OM, Puskas JD, Kilgo P, Cooper WA, Morris CD, Thourani VH. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery. Ann Thorac Surg. 2008;86(5):1431–7. doi: 10.1016/j.athoracsur.2008.06.078.
    1. Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V, Borger MA. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2005;130(4):1144–e1. doi: 10.1016/j.jtcvs.2005.05.049.
    1. Bhamidipati CM, LaPar DJ, Stukenborg GJ, Morrison CC, Kern JA, Kron IL, Ailawadi G. Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2011;141(2):543–51. doi: 10.1016/j.jtcvs.2010.10.005.
    1. Leibowitz G, Raizman E, Brezis M, Glaser B, Raz I, Shapira O. Effects of moderate intensity glycemic control after cardiac surgery. Ann Thorac Surg. 2010;90(6):1825–32. doi: 10.1016/j.athoracsur.2010.07.063.
    1. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland diabetic project. Endocr Pract. 2004;10:21–33. doi: 10.4158/EP.10.S2.21.
    1. Lazar HL. Glycemic control during coronary artery bypass graft surgery. ISRN Cardiol. 2012;2012:292490. doi: 10.5402/2012/292490.
    1. Azevedo JR, Azevedo RP, Lucena LC, Costa ND, Silva WS. Impact of glycemic control on the incidence of acute kidney injury in critically ill patients: a comparison of two strategies using the RIFLE criteria. Clinics. 2010;65(8):769–73. doi: 10.1590/S1807-59322010000800005.
    1. Haga KK, McClymont KL, Clarke S, Grounds RS, Ng KY, Glyde DW, Alston RP. The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity: a systematic review and meta-analysis. J Cardiothorac Surg. 2011;6:3. doi: 10.1186/1749-8090-6-3.
    1. Lazar HL, McDonnell MM, Chipkin S, Fitzgerald C, Bliss C, Cabral H. Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Ann Surg. 2011;254(3):458–64. doi: 10.1097/SLA.0b013e31822c5d78.
    1. Kramer R, Groom R, Weldner D, Gallant P, Heyl B, Knapp R, Arnold A. Glycemic control and reduction of deep sternal wound infection rates: a multidisciplinary approach. Arch Surg. 2008;143(5):451–6. doi: 10.1001/archsurg.143.5.451.
    1. Trick WE, Scheckler WE, Tokars JI, Jones KC, Reppen ML, Smith EM, Jarvis WR. Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2000;119(1):108–14. doi: 10.1016/S0022-5223(00)70224-8.
    1. Jacobi J, Bircher N, Krinsley J, Agus M, Braithwaite SS, Deutschman C, Schunemann H. Guidelines for the use of an insulin infusionfor the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40:3251e76. doi: 10.1097/CCM.0b013e3182653269.
Pre-publication history
    1. The pre-publication history for this paper can be accessed here:

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner